Multiple System Atrophy clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
The objective of this randomized, double-blinded, placebo-controlled Phase 1 investigation is to evaluate the safety and potential clinical effect of AAV2-GDNF delivered to the putamen in subjects with either a possible or probable diagnosis of Multiple System Atrophy.
Irvine, California and other locations